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T  helper cells recognize exogenous antigens  in association with class II histocom- 
patibility  antigens  (Ia antigens)  on the surface of an antigen-presenting  cell  (APC) 1 
(reviewed in reference  1). The best-studied  APC (mononuclear phagocytes, dendritic 
cells,  Langerhans  cells)  are  derived  from  bone  marrow  precursors.  In  mouse,  the 
ability of a population of macrophages to present antigen correlates with the propor- 
tion  of macrophages  that  expresses  Ia  (2).  Similar  results  have  been  noted  with 
macrophage cell lines (3). T  helper cells, when activated, secrete a lymphokine(s) that 
recruits  Ia-positive macrophages  from the bone marrow in vivo (4)  and  induces  Ia- 
negative macrophages to express Ia in vitro (5-7). Thus, T  cells can recruit additional 
functional  APC  to  amplify  the  immune  response.  Two  preliminary  reports  have 
suggested that human mononuclear phagocytic cells may be under similar control (8, 
9). 
Recent data (10,  11) have suggested that cultured human vascular endothelial cells 
may substitute  for bone marrow-derived  APC,  presenting  antigen  to immunized  T 
cells  in  vitro  in an  Ia-restricted  manner.  In these  experiments,  contaminating  bone 
marrow-derived APC, especially dendritic cells, could have accounted for the results. 
Furthermore,  Ia antigens  could not  be demonstrated  on cultured  human  umbilical 
vein  endothelial  cells  by  indirect  immunofluorescence  using  a  mouse  monoclonal 
antibody  (8,  12).  Recently  (i3),  we have  shown  that  although  primary  isolates  of 
human  umbilical  vein  endothelial  cells  do  not  express  Ia  antigens  under  standard 
culture  conditions,  they may be induced  to do so by treatment  of the cultures  with 
phytohemagglutinin (PHA). In this paper, we report that the induction of endothelial 
Ia can be mediated by activated T  cells as shown by transfer of medium conditioned 
by activated T  ceils, by co-cuhivation with  allogeneic T  cells,  and by addition  of y 
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interferon, an activated T  cell product. Thus, this similarity of T  cell regulation of Ia 
expression on endothelial cells and classic APC supports the hypothesis that  vascular 
endothelium may indeed function to present antigen. 
Materials  and  Methods 
Cells.  Human  umbilical  vein  endothelial  (HUVE)  cells  were  harvested  by  collagenase 
treatment  of two  to  six  normal  term  umbilical cord  segments and  pooled  in  Medium  199 
containing 20%  (vol/vol)  heat-inactivated fetal  bovine serum supplemented with  125  U/ml 
penicillin, 125 #g/ml streptomycin, and 2 mM L-glutamine (M199-FBS; all components from 
M. A. Bioproducts, Walkersville, MD) as described elsewhere (14).  Replicate primary cultures 
were plated (day 0) in either Costar 96 flat-bottomed microtiter wells (0.32 cm2/well) or Costar 
24 flat-bottomed wells (2.0 cm2/well, both from M. A. Bioproducts). The cultures were washed 
(day 1) to remove unattached blood and endothelial cells and re-fed with M199-FBS. Cultures 
normally reached visual confluence (~0.75 ×  105 cells/era  2) by day 3. 
Peripheral  blood  mononuclear cells were  sterilely isolated  from  heparinized  (5%  vol/vol 
heparin,  1,000 USP U/ml; Elkins-Sinn, Inc., Cherry Hill, NJ)  adult peripheral venous blood 
by density step gradient centrifugation (15) using lymphocyte separation medium (LSM; Litton 
Bionetics, Inc., Kensington, MD). T  cells and T  cell subsets were also sterilely purified from 
adult peripheral venous blood. To prepare T  cells, blood was defibrinated with glass beads, 
depleted  of red  cells by  1 g  sedimentation through  3%  dextran  in HEPES-buffered  Hanks' 
balanced saline solution (HBSS)  and the erythrocyte-poor fractions were  further purified by 
density step gradient centrifugation as above. The mononuclear cells from the interface were 
incubated  on  plastic  for  1 h  to  remove  adherent  cells,  washed,  and  then  incubated  with 
neuraminidase-treated sheep erythrocytes (Flow Laboratories, Inc., McLean, VA) for 15 min at 
37°C  in suspension and  1 h  at  4°C  as a  pellet  to  form  rosettes.  Rosettes  were  collected by 
sedimentation through ice-cold LSM and washed in HEPES-buffered HBSS with 5% FBS; the 
sheep  erythrocytes  were  lysed  with  buffered ammonium chloride.  Finally, the T  cells were 
further  depleted  of  adherent  cells  by  an  additional  overnight  incubation on  plastic.  This 
population stained >95% positive with mouse monoclonal antibody Leu-1  (Becton, Dickinson 
& Co.,  Sunnyvale, CA).  T  cell subsets (i6)  were  prepared  by cell sorting of cells stained by 
indirect  immunofluorescence using mouse  monoclonal antibody  OKT4  (Ortho  Diagnostic 
Systems Inc., Westwood, MA) diluted  1:100 in HBSS with 4% wt/vol bovine serum albumin 
and fluorescein-conjugated rabbit anti-mouse immunoglobulin, F(ab')2 fragment at 0.5 mg/ml 
in the same buffer. Staining and sorting were performed at  ice temperature using a  FACS II 
cell sorter (B-D FACS Systems, Becton, Dickinson & Co.). The purity of the sorted cells was 
assessed by reanalyzing the sorted population using the same criteria used for sorting. 
Treatment of Primary HUVE Cultures.  HUVE cell cultures were treated by addition of 4/*g/ 
ml  PHA  (type  IV  leucoagglutinin;  Sigma  Chemical  Co.,  St.  Louis,  MO)  or  conditioned 
medium in M199-FBS on either day  1 (subconfluent) or on day 4  (at  confluence). Medium 
conditioned by  activated  peripheral  blood  mononuclear cells  was  produced  by  incubating 
peripheral blood mononuclear cells in M199-FBS containing 4 #g/ml PHA at 2 X  10  ~ cells/ml 
for 24 h  at  37°C in a  humidifed 5% CO2 environment. This medium was used undiluted in 
place of fresh M 199-FBS. Media conditioned by clones derived from the Jurkat T  cell line were 
gifts of Dr. Jack Strominger (Sidney Farber Cancer Institute, Boston, MA) and Dr. Terry Strom 
(Brigham and Women's Hospital, Boston, MA). These were used at concentrations from 0.1 to 
10% (vol/vol) in M199-FBS and were compared with matched control media not incubated 
with cells. Finally, media containing human ?, interferon were produced by a  cloned Chinese 
hamster ovary cell line transfected wilh a plasmid containing the human y interferon gene (17). 
Characterization of the cloned cell line is  to  be described  in detail  elsewhere.  This cell line 
constitutively secretes human y interferon. Matching medium from a cloned Chinese hamster 
ovary cell line not containing the y interferon gene was used as a  control. These conditioned 
media were added at concentrations of 0.2-10% (vol/vol) in M 199-FBS. None of the mitogens 
or conditioned media showed any cytopathic effect upon the HUVE cells at the concentrations 
used in these experhnents. 
Co-Culture of HUVE  Cells with Per2])heral Blood Cells.  Confluent HUVE cell monolayers in POBER  ET  AL.  1341 
Costar 24 wells were washed and re-fed with M I99-FBS containing peripheral blood mono- 
nuclear cells or subsets of peripheral blood mononuclear cells, isolated as described above. Cell 
ratios ranged from <1  peripheral blood cell  to 20 peripheral blood cells per HUVE cell.  In 
some experiments, either the HUVE culture, the peripheral blood cells, or both were  given 
1,200 rad of y irradiation from a  cesium source (Gammacell 40;  Atomic Energy of Canada 
Ltd., Commercial Products, Ontario, Canada) prior to co-cuhure. Finally, in some experiments, 
10%  (vol/vol) heat-inactivated noncytotoxic human serum (Bio  Bee, Boston, MA) was used 
instead of 20% FBS. 
Monoclonal Antibody Binding.  Mouse monoclonal antibody binding to the surface of HUVE 
cells was examined by double antibody radioimmunoassay, by immunocytochemistry,  and by 
fluorescence flow cytometry (all described below). The mouse monoclonal antibodies used were 
W6/32 (IgGz,,  directed against an HLA-A,B monomorphic heavy chain determinant [18], a 
gift of Dr. Jack Strominger); LB3.1  (IgG2b, against an HLA-DR monomorphic determinant, 
characterization unpublished, a gift of Dr. Peter Knudsen and Dr. Jack Strominger); I2 (IgG2a, 
also  against  an  HLA-DR  monomorphic determinant, [19]),  LLR1  (IgG2b, against  an  SB 
polymorphic determinant [19, 20]), I-LR2 (IgG~, against a polymorphic human Ia determinant 
[19], all three gifts of Dr. Lee Nadler, Sidney Farber Cancer Institute), and Genox 3.53 (IgG1, 
against the DC-1  human Ia antigen [21], gift  of Dr.  Frances Brodsky,  Stanford University, 
Stanford, CA).  K1210  (IgG1), MPCll  (IgG2b), and UPC10  (IgG2,) were nonbinding mouse 
immunoglobutins  used as negative controls, obtained from Dr. Donna Mendrick (Brigham and 
Women's Hospital), Dr. Abul Abbas (Brigham and Women's Hospital) and Walgene R  & D 
Laboratories, Inc. (Arcadia, CA), respectively. Second antibodies were a25I-labeled sheep anti- 
mouse immunoglobulin,  F(ab')z fragment from New England Nuclear (Boston, MA); horserad- 
ish peroxidase conjugated rabbit anti-mouse immunoglobulin,  a gift of Dr. Donna Mendrick; 
or fluorescein-conjugated rabbit anti-mouse immunoglobulin from  Miles Laboratories Inc., 
Elkhart, IN. 
Double antibody radioimmunoassay was  performed  using confluent HUVE  cultures  in 
Costar 96 microtiter wells as described elsewhere  (13). Immunocytochemistry at the electron 
microscope level  (22) was performed using HUVE cultures or co-cultures of HUVE cells and 
blood  cells  in  Costar  24  wells.  In  brief,  cells  were  stained as  for  radioimmunoassay with 
saturating amounts of mouse monoclonal antibodies in 500/xl  and detecting antibody in 250 
/11 of 1% (wt/vol) bovine serum albumin (Sigma Chemical Co.) in HBSS (with calcium; M. A. 
Bioproducts);  the  detecting  antibody was  rabbit  anti-mouse immunoglobulin coupled  to 
horseradish peroxidase. After the final wash, the cell monolayer was lightly fixed with  1.25% 
glutaraldehyde in 0.1  M  sodium eacodylate, pH  7.4, for  2 h  at 4°C and then washed three 
times with 0.05  M  Tris-HCl, pH  7.56 (Tris buffer). The cells were incubated with diamino- 
benzidine and hydrogen peroxide  (5  mg diaminobenzidine, 0.1  ml of 1%  H202/10  ml Tris 
buffer) for 40 rain at room temperature, and excess substrate was removed by three washes 
with Tris buffer. Each well was post-fixed  with 2% aqueous osmium tetroxide for 30 min at 
room temperature and then dehydrated and embedded in Epon, and the monolayer was re- 
embedded at right angles to the original plane of the culture dish to obtain cross-sections. These 
sections were examined by electron microscopy using a Philips 201 electron microscope (Philips 
Electronic Instruments, Inc., Mahwah, N  J). 
Immunofluorescence flow cytometry was performed using HUVE cultures or co-cultures of 
HUVE cells  plus blood cells  in Costar  24 wells.  Cells were suspended by two washes  with 
calcium-free HBSS followed  by incubation with trypsin-versene mixture (M. A. Bioproducts) 
for 5 min at 37~C. After gentle tituration with a pasteur pipette, the trypsin was quenched by 
addition of M 199-FBS. This protocol yields a nearly monodisperse suspension (a few lympho- 
cyte-endothelial couplets persist)  of trypan blue dye-excluding cells and does not alter staining 
for  Ia  antigens. The  suspension was  washed  twice with bovine serum  albumin-Dulbecco's 
phosphate-buffered saline using the clinical centrifuge and labeled as for the radioimmunoassay 
with saturating amounts of monoclonal antibodies and detecting antibody (fluorescein  isothi- 
ocyanate [FITC]-rabbit anti-mouse immunoglobulin).  The final washed cell pellets were fixed 
by suspension in freshly made  1% paraformaldehyde (Fisher Scientific Co., Pittsburgh, PA). 
Fixed cells were stored for up to several days in the dark at 4°C prior to analysis. 
Analysis was performed by flow cytometry using a  FACS Analyzer (B-D  FACS Systems, 1342  T  CEI,LS INDUCE VASCULAR ENDOTHELIAL  Ia 
Becton, Dickinson & Co., Sunnyvale, CA) with a  100-#m orifice to permit entry of endothelial- 
sized cells. Data were obtained on both electronic cell volume and immunofluorescence  of each 
cell passing through the orifice. Endothelial-sized cells form a distinct cluster on the volume vs. 
fluorescence  intensity plot either when analyzed alone or when mixed with blood mononuclear 
cells. Blood mononuclear cells, analyzed alone, are much smaller and do not overlap with the 
endothelial cells.  Gates  were  empirically set  to  exclude small cells  (e.g.,  lymphocytes)  and 
subcellular debris from analysis. Data was normally collected and displayed as a histogram of 
cell number (y axis)  vs. log fluorescence intensity (x axis);  anti-Ia was always compared with 
nonspecific binding of an unreactive mouse monoclonal antibody of the same immunoglobulin 
class. 
Treatment of HUVE Cultures with  OKT3 plus  Complement.  HUVE monolayers, confluent or 
subconfluent, were washed once with L15 medium (M. A. Bioproducts) and incubated for 30 
min at room temperature in mouse monoclonal antibody diluted in L15;  for OKT3 (Ortho 
Diagnostic Systems Inc., Westwood, MA), the effective  dilution was  1:10. Further dilutions 
(e.g.,  1:50) have  given  variable results.  Excess  antibody was  removed  and  the  cells  were 
incubated in pooled baby rabbit complement (Pel Freez Biologicals,  Rogers,  AR) diluted 1:1 
with  L15  for  30  min at  37°C  in a  humidified, 5%  CO2  incubator. The  complement was 
removed and replaced by fresh  complement (t:1 with L15)  for a second 30-min incubation. 
The cells were then washed and re-fed with M 199-FBS with or without specific effectors  (e.g., 
PHA). The complement treatment did not appear cytopathic to the endothelial cells. 
Proliferation of  T  Cells.  T  cell  proliferation to  allogeneic endothelial cells,  to  allogeneic 
peripheral blood cells, or to mitogenic lectin have all been assessed by [aH]thymidine incorpo- 
ration into DNA. T  cells were incubated with allogeneic irradiated stimulator cells (1,200 rad 
-f irradiation from a cesium source)  in triplicate in Costar 96 flat-bottomed microtiter wells in 
200 /B  vol.  HUVE cells were  present as  a confluent monolayer (~1.5  X  104 cells/well) and 
allogeneic peripheral blood mononuclear cells were added in suspension (1 X 105 cells/well). In 
some experiments, the effect of the number of stimulator peripheral blood mononuclear cells 
was assessed, adding as few as  1 ×  104; no stimulation was observed below 3 ×  104. Peripheral 
blood mononuclear cells, purified T cells, and T cell subsets have been used as responder cells 
varying from  1.5 ×  104 to 3 ×  10  ~ cells/well; most assays use 3 X  105 cells. Incubations were 
conducted in medium M199 containing 10% (vol/vol) heat-inactivated human serum (noncy- 
totoxic), but 20%  FBS may be substituted without apparent effect.  The onset of co-culture 
marks the beginning  of day 1; proliferation was assessed by adding 1 ~Ci [aH]thymidine (New 
England Nuclear) 18 h before harvest and is numbered by the day on which incubation started 
(e.g.,  day  3  proliferation is  harvested  72  h  after  the  onset  of co-culture). Incorporation of 
radioactivity into DNA was measured by automated harvest (mini-MASH; M. A. Bioproducts) 
with collection of macromolecules on a filter and subsequent liquid scintillation  counting. Each 
point was determined in triplicate and corrected for incorporation into the unstimulated cell 
population(s) incubated separately, also determined in triplicate. 
Results 
Endothelial  Cells May Be Induced to Express Ia Antigens.  We have previously reported 
that  HUVE  cells in primary culture, under standard conditions, do not express  Ia 
antigens, but that  treatment of the cultures with the plant lectin PHA induces the 
expression  of  endothelial  cell  Ia  (13).  The  expression  of  Ia  by  the  culture  was 
quantified by monoclonal antibody binding, measured in a double antibody radioim- 
munoassay; the  increase in binding was  confirmed to  be an  increase in Ia antigen 
expression by immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel 
electrophoretic analysis of radiolabeled cell surface protein. We have now determined 
the percentage of Ia-positive cells by fluorescence flow cytometry, using an  FITC- 
conjugated anti-mouse Ig immunoglobulin  as the second antibody. LB3.1  binding to 
endothelial cells in untreated cultures (Fig.  1 A, large dots)  is indistinguishable from 
nonspecific binding with a  mouse myeloma protein (small dots);  in contrast, in the A 
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FIG.  1.  Mouse  monoelonal  anti-human  Ia antibody binding to  endothelial  cells analyzed  by 
fluorescence flow cytometry. The data are presented as histograms, plotting cell number ~ axis) vs. 
log fluorescence intensity (x axis). The binding of LB3.1 (monomorphic anti-HLA-DR large dots, 
panels A and C) and I-LR1 (polymorphic anti-$B, large dots, panels B and D) are compared with 
a nonspecific mouse immunoglobulin  (small dots) in PHA-treated (C and D) and untreated (A and 
B) cultures. Note that binding of LB3.1 and ]-LR 1 is indistinguishable  from control in untreated 
cultures, that every endothelial cell is HLA-DR-positive in the treated cultures, and that ~40% of 
these cells from pooled donors bind I-LR1 after PHA treatment.  We interpret this to mean that 
every cell expresses SB antigens but that only 40% of the cells genetically encode for an SB antigen 
recognized by I-LR 1. 
PHA-treated cultures, the entire population has become HLA-DR-positive (Fig. 1 B). 
An  incidental  but  reproducible finding is  that  Ia-positive endothelial cells appear 
slightly smaller as judged  by electronic volume than  Ia-negative cells. This  change 
probably correlates with the change in cell shape noted previously (13). 
Several human  Ia antigens in addition to HLA-DR  have been recently described. 
The  mouse  monoclonal  antibody I-LR1  is a  polymorphic reagent that  recognizes a 
subset of allelic products of the SB locus (20). Endothelial cells in untreated cultures 
derived from several pooled donors appear SB-negative (i.e., do not bind I-LR 1, Fig. 
1 C)  and upon PHA treatment,  ~40% of the endothelial cells bind I-LR1  (Fig.  1 D), 
whereas ~60% of the cells remain indistinguishable from the untreated control. This 
result  has two  implications. First, it shows  that  more than  one  Ia antigen  (DR and 
SB)  are coordinately induced.  Similar results by  radioimmunoassay have  been  ob- 
tained for mouse monoclonal antibodies Genox 3.53 and I-LR2 polymorphic reagents 
that  recognize products  of other  human  Ia  loci  (not  shown).  Second,  the  fact  that 
~40% of the cells in these pooled cultures become discretely I-LR 1 binding, whereas 
-60% remain nonbinding (a bimodal distribution), suggests that each endothelial cell 
synthesizes  its  own  Ia.  According to  this  interpretation,  every cell  has  become  SB 
antigen-positive, but  only 40%  of the cells genetically encode for SB antigens recog- 
nized  by  I-LRI.  If,  on  the  other  hand,  Ia  were  being shed  into  the  medium  and 
passively bound  by endothelium,  it would be expected that  every cell should  have 1344  T  CELLS INDUCE VASCULAR ENDOTttELIAL  Ia 
become I-LR1 reactive to some degree, as was seen with the monomorphic anti-HLA- 
DR antibody LB3.1  (Fig.  1, A  and C). 
The Induction of Endothelial Ia by PHA Is Mediated by T Cells.  PHA could act directly 
upon endothelial cells to induce Ia expression or could activate a minor cell population 
in the culture, which in turn would act upon endothelial cells or could do both. The 
most  likely candidate  for  a  mediator  cell  is  the  T  lymphocyte.  T  cells  were  not 
detectable in the primary HUVE cultures by morphology or by monoclonal antibody 
binding assays with the anti-human T  cell mouse monoclonal antibodies OKT3 or 
Leu-1. Furthermore, the cultures were multiply washed, a  condition not expected to 
retain T  cells,  a  nonadherent (to  plastic)  cell  type.  Nevertheless,  T  cells could  be 
involved because  (a)  T  cells,  although nonadherent to  plastic,  bind tenaciously to 
cultured vascular endothelium (23, and personal observations); (b)  in general, very 
few T  cells can produce enough lymphokine to affect many target cells; and (c) both 
PHA  and  concanavalin A  (Con  A),  another  potyclonal  T  cell  activator,  induce 
endothelial Ia expression at doses that activate T  cells. 
Direct evidence for the role of T  cells in mediating endothelial Ia expression was 
obtained by the following experiment. Primary HUVE cultures were treated either 
with complement alone (mock-treated) or with anti-human T  cell mouse monoclonal 
antibody OKT3 plus complement before the addition of PHA.  Endothelial cells in 
cultures treated  with  OKT3  plus complement  no  longer express  Ia  in  response to 
PHA, whereas mock-treated cultures respond as usual (Fig.  2).  Similar results were 
obtained with Con A  (data not shown). In other experiments, use of mouse myeloma 
16,000 
14,000 
12,000 
I0,000 
8.000 
6,O00 
4,000 
2,000 
0 
"o 
g 
133 
,_,= 
v 
g 
o~ 
UJ 
o 
C  I  Only  OKT3 +  C / 
1  I  I 
Untreated  PHA 
i 
Untreated  PHA  PHA-PBL y-IFN  Control 
CM  Medium  Medium 
Yre0tmenl 
FIG. 2.  Effect of OKT3  plus complement pretreatment  upon the induction of endothelial Ia. 
Replicate HUVE primary cultures were plated oil day 0, treated with OKT3 plus complement or 
complement alone on day l, and immediately treated with fresh MI99-FBS (untreated), M199-FBS 
containing 4/*g/ml Pt tA, M 199-FBS conditioned for 24 h by 2 X 1()  ~  peripheral blood mononuclear 
cells/ml in 4 ,ag/ml PHA (PHA-PBL CM), and MI99-FBS containing 1% Chinese hamster ovary 
cell conditioned medium by cells expressing human y interferon (T-IFN  medium containing 5 X  10  4 
U/ml assayed on FS4 cells) and not expressing  human y interferon (control medium). Cultures were 
assayed for Ia expression by double antibody radioimmunoassay  on day 4. POBER  ET  AL.  1345 
proteins or mouse monoclonal antibodies not reactive with human T  cells of the same 
immunoglobulin class as OKT3  plus complement also had no effect upon the PHA 
response  (data not  shown).  There  was  no  evidence of a  cytopathic effect upon  the 
endothelial  cells after  treatment  with  OKT3  plus  complement.  Most  importantly, 
medium conditioned by human  peripheral blood mononuclear cells treated with the 
same dose of PHA was effective in inducing endothelial cell [a expression even after 
treatment with OKT3  plus complement  (Fig. 2). The efficacy of different samples of 
conditioned medium was  variable, which suggests that  a  labile factor was involved. 
The role of a  T  cell factor in the induction of endothelial Ia was further suggested by 
the following two types of experiments. 
Co-Culture with Allogeneic  T  Cells Induces Endothelial Ia in the Absence  of Lectin.  When 
peripheral  blood  mononuclear  cells  from  an  adult  donor  are  co-cultured  with  an 
allogeneic HUVE  cell monolayer, the T  cells proliferate (24, and Fig. 3), with a  peak 
of proliferation on  day 6.  The  time course of this response  is similar to  that  of the 
response  to  allogeneic  blood  cells.  Although  the  primary  HUVE  cultures  contain 
some blood cells, these do not appear to be present in sufficient quantity to account 
for the proliferation. Specifically, the HUVE  cultures morphologically contain <1  × 
103  blood mononuclear cells and  1 X  104  blood mononuclear cells do not stimulate 
proliferation. By trypsin treatment, we have been able to disperse the cell cultures at 
various times after initiation of co-culture and  have  tested  for Ia expression by the 
endothelial-sized cells, using the fluorescence flow cytometer. Very few endothelial- 
sized cells express Ia at the onset of co-culture  (i.e., at  30 min);  however,  increasing 
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Fro. 4.  Time course of the induction  of endothelial  Ia induced  by co-culture  with  allogeneic 
peripheral blood mononuclear cells, assayed by fluorescence flow cytometry. The data are presented 
as histograms, plotting cell number (y axis) vs. log fluorescence intensity  (x axis). LB3.1 binding 
(mouse monoclonal  anti-human  HLA-DR, large  dots)  is compared with  nonspecific antibody 
binding (small dots) after (A) 15 rain, (B) 24 h, (C) 48 h, and (D) 72 h of co-culture. 
numbers of cells are positive at  24,  48,  and  72  h.  In  fact, by  72  h,  almost all of the 
endothelial-sized cells  are  Ia-positive  (Fig.  4).  By  immunocytochemistry,  we  have 
confirmed that the Ia-positive large cells are morphologically identifiable endothelial 
cells (Fig. 5).  By fluorescence flow cytometry and immunocytochemistry, most of the 
small cells remain Ia-negative. 
These  results have  four implications.  First, incubation  with  allogeneic peripheral 
blood mononuclear cells induces  Ia in  the absence of lectin. The exogenous T  cells 
appear to be the important  effectors because OKT3  plus complement  pretreatment 
of the  HUVE  cultures  has  no  effect  upon  Ia  induction  (data not  shown).  Second, 
endothelial  Ia  expression  precedes  T  cell  proliferation, which  suggests  that  T  cell 
activation  but  not  proliferation  is  needed  for  Ia  induction.  In  fact,  y  irradiation 
(1,200  rad) of the blood cells to prevent proliferation does not alter the induction of 
endothelial  Ia  (data  not  shown).  Third,  the  presence  of discretely Ia-negative and 
positive endothelial cells in the culture at 24 and 48 h  again suggests that endothelial 
cells synthesize Ia rather than absorb Ia shed by other cells into the medium. Finally, 
Ia appears sufficiently early in the co-culture that  it could be a  major stimulator of 
allogeneic T  cell proliferation in the response to endothelium, as has been shown  in 
the mixed lymphocyte reaction (reviewed in reference 25). 
The  peripheral  blood  mononuclear  cells  added  to  HUVE  cells  in  the  previous 
experiment are predominantly T  cells, but contain several other cell types. To better 
establish  a  role  for T  cells in  this  phenomenon,  we  further  fractionated  the  blood 
mononuclear cells. Fractions enriched for T  cells by E-rosette formation retained Ia- 
inducing activity (data not shown).  After overnight adherence to plastic, the T  cell- 
enriched  population  was  further  separated  into  the  OKT4-positive  (>96%  OKT4- POBER  ET  AL.  1347 
FIc~.  5.  Immunocytocbemical localization  of mouse monoclonal  (A)  anti-human la  (LB3.I)  and 
(B)  anti-human  T  cell  (Leu-1)  antibodies  to  cells  in  co-culture  of human  endothelium  with 
peripheral blood  mononuclear cells after 72 h. Most of the morphologically identified endothelial 
cells (lower ceils in both panels) were la-positive, whereas most of the T  ceils (upper ceils in both 
panels)  were  Ia-negative.  This  result  confirms that  the  Ia-positive  large  cells  analyzed  by  flow 
cytometry (Fig. 4) represent endothelial cells. 1348  T  CELLS  INDUCE VASCULAR  ENDOTtlELIAL  Ia 
TABLE  I 
Endothelial Ia expression 
Lymphocytes added  (Relative fluorescence in- 
tensity) 
None  1.0 
1 x  l0  s OKT4-positive  2.6 
3 X  l0  n OKT4-positive  2.0 
1 ×  l0  n OKT4-positive  1.1 
1 X  l0  s OKT4-negative  1.9 
3 X  10  n OKT4-negative  1.0 
i  X  10  '~ OKT4-negative  l.i 
OKT4-positive or -negative T  cells,  purified  by cell  sorting as "described  in 
Materials and Methods, were placed in co-culture with  1.5 X  I06 HUVE cells 
for 72 h. Endothelial cells were harvested, fluorescently labeled  for HI,A-DR 
antigens with  LB3.1,  and  analyzed  by  fluorescence  flow  cytometry,  also  as 
described in Materials and Methods. The data are presented as the mode of 
the fluorescence intensity relative to a nonreactive mouse myeloma protein. 
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FiG.  6.  Dose-response  curve for the induction of endothelial Ia by conditioned media from Chinese 
hamster ovary cell  lines  that do (+y-IFN) or do not (-T-IFN) secrete human y interferon (5 ×  l04 
U/ml assayed on FS4 cells).  Replicate primary HUVE cultures were plated on day 0, treated with 
M I99-FBS  containing  various concentrations  of control  or  y  interferon-containing conditioned 
medium on day  1, and assayed for Ia expression by double antibody radioimmunoassay on day 4. 
The maximum amount of Ia expressed, in other experiments, appears to be about one-fifth that 
expressed perJY human B lymphoblastoid cell. 
positive) and OKT4-negative  (<2%  OKT4-positive) subsets by means of the fluores- 
cence-activated cell sorter. Both of these cell populations still proliferated in response 
to  PHA  or  to  an  allogeneic B  cell  lymphoblastoid line,  which  suggests  that  some 
residual  APC  remained.  Whereas whole  peripheral blood mononuclear  cells fail to 
induce endothelial Ia below a  10:1  ratio  (1.5  X  106  mononuclear cells per  1.5  X  105 
HUVE  cells in a  flat-bottomed Costar 24 well, surface area 2.0 cm2), both the OKT4 + 
and OKT4-  subsets were effective endothelial Ia inducers at  1.0 X  106 cells/well and 
the OKT4 + subset was still active at  3.0  ×  105 cells (Table I). Thus,  T  cell-enriched 
fractions are more potent endothelial Ia inducers than  total peripheral blood mono- 
nuclear  cells and  monocyte-enriched  fractions  do  not  have  discernible Ia-inducing 
activity. These data suggest the activity resides in the T  cell population. POBER ET AL.  1349 
T  Interferon Induces Endothelial  Cell  Ia  Expression.  As  shown  earlier,  conditioned 
medium from PHA-activated peripheral blood mononuclear cells induced endothelial 
cell Ia expression in primary HUVE cultures treated with OKT3 plus complement. 
To establish that  T  cells were the source of the factor(s), we have examined several 
preparations of known human lymphokines. Conditioned medium from some clones 
of the Jurkat  T  cell line,  a  known  producer of lymphokines  (26),  were effective Ia 
inducers, whereas medium conditioned by other clones did not work; this activity did 
not correlate with measurable interleukin 2  (data not shown). 
Recently, the gene for human Y interferon has been cloned in a  plasmid (17)  and 
introduced into a Chinese hamster ovary cell line, and clones have been isolated that 
constitutively secrete y  interferon  into  the medium.  We compared the activity of y 
interferon-containing conditioned medium with that of conditioned medium from a 
matching Chinese hamster ovary cloned cell line not containing the 3' interferon gene. 
Whereas the control conditioned medium had no Ia-inducing activity, the T interferon 
preparations have extremely potent endothelial cell Ia-inducing activity (Figs. 2 and 
6). Thus, y interferon, a protein produced by activated T  cells, induces endothelial Ia. 
Discussion 
Recent  studies  (10,  11)  have suggested  that  human  vascular endothelial  cells  in 
culture can act as immune accessory cells, presenting antigen to immunized T  cells in 
an  Ia-restricted manner.  Since  contaminating  bone  marrow-derived APC  could  be 
present, a  demonstration that the endothelial cells in these cultures were, in fact, Ia- 
positive is necessary to support the interpretation that endothelial cells can function 
as APC. 
HLA-DR typing sera and rabbit anti-human  Ia xenosera have been shown to be 
cytotoxic for cultured HUVE cells (27-29).  However, these sera may cross-react with 
alloantigens other than  Ia (e.g., endothelial-monocyte alloantigens not expressed on 
lymphocytes).  More  recent  reports  (8,  12)  using  binding  of  mouse  monoclonal 
antibodies  reactive with  human  Ia analyzed  by  fluorescence  flow cytometry have 
reported that  human endothelial  cells in culture are Ia-negative. Our earlier results 
(13) demonstrated that HUVE cells do not bear Ia under standard culture conditions, 
but that Ia could be induced  in culture.  Here we extend these observations to show 
that  every HUVE  cell  synthesizes  and  expresses Ia and  that  T  cells,  activated by 
lectin or alloantigen, mediate the induction of endothelial Ia. T  cells appear to work, 
at least in part, by release of soluble mediators (i.e., conditioned medium induces Ia) 
and that y interferon, a  protein secreted by activated T  cells, acts directly to induce 
endothelial Ia. Therefore, experiments that have used HUVE cell cultures to support 
antigen- or lectin-dependent  T  cell proliferation  (10,  11,  30)  may have started with 
Ia-negative  endothelial  cell  populations,  but  our  results  predict  that  once  T  cell 
activation has begun, perhaps with residual  contaminating monocytes in the T  cell 
population acting as APC, the activated T  cells will induce endothelial Ia expression, 
recruiting additional APC in vitro. 
There are two previous reports  that  suggest  that  some endothelial  cell  functions 
may be under lymphocyte control. First, medium conditioned by the human lympho- 
blastoid cell line RPMI 8392 or by activated (by lectin or antigen)  peripheral blood 
mononuclear cells inhibit  the migration  of bovine endothelial  cells in culture  (31). 
Second,  supernatants  from mixed lymphocyte cultures appear mitogenic for bovine 1350  T  CELLS INDUCE VASCULAR ENDOTHELIAL Ia 
endothelial cells (32).  Human leukocyte (c~) interferon has also been shown to inhibit 
the migration of bovine endothelial cells (33), hut immune (Y) interferon has not been 
tested. 
Endothelial Ia arises early in the course of co-culture with T  cells; about one-third 
of the cells are Ia-positive by 24 h. For this reason, we have suggested that endothelial 
Ia could be a  major stimulator of the subsequent  T  cell proliferation, just as it is in 
the response to allogeneic blood mononuclear cells (25). This hypothesis needs to be 
tested. What activates exogenous allogeneic T  cells before Ia is induced? It is possible 
that a  small number of Ia-positive cells are present  in  the primary HUVE cultures, 
either a subpopulation of endothelium or, more likely, a contaminating population of 
bone marrow-derived APC  (monocytes, tissue  macrophages, or dendritic  cells).  Al- 
though these cells are few, they could trigger an occasional responding T  cell to release 
an endothelial cell Ia-inducing factor, perhaps y interferon. Alternatively, the exoge- 
nous T  cells have been added with their own APC, even in the case of our enriched 
T  cell subsets, and these APC can function to present foreign HLA-A,B antigens that 
are clearly expressed in untreated cultures.  Presentation of alloantigens by syngeneic 
APC has been seen in the murine mixed lymphocyte reaction (34). 
The induction  of endothelial  Ia by activated T  cells has a  striking parallel in the 
induction of murine macrophage Ia by activated T  cells. The factor(s) responsible for 
macrophage Ia induction  may be y  interferon,  but  the  identity  of the  Ia-inducing 
factor has not been established.  Preparation of partially purified murine y interferon 
increases the percentage of Ia-positive thymocytes, but the authors of this report could 
not distinguish between induction of Ia or selection for Ia-positive cells (35).  Human 
monocyte Ia may be regulated  (8,  9), but these cells are uniformly Ia-positive upon 
isolation and Ia quantitatively increases in culture without additional  perturbations 
(36).  Therefore, induction of Ia in human monocytes has been difficult to study. The 
human endothelial cell system thus has two clear experimental advantages: (a) human 
y interferon, through the techniques of molecular genetics, is available free of all other 
contaminating human proteins, whereas mouse 3' interferon of similar purity is not 
yet available; and (b) untreated endothelial cells in culture are uniformly Ia-negative 
and may be uniformly induced to express Ia. The present report offers evidence that 
y interferon does induce endothelial cell Ia and thus accounts for at least some of the 
Ia-inducing activity of medium conditioned by activated lymphocytes or T  cell lines. 
These results differ from those recently reported using cloned human y interferon to 
treat a  B lymphoblastoid cell line; HLA-A,B antigens were increased but Ia antigens 
were not affected (37). 
A biological role for endothelial Ia expression in vivo is not clear. Endothelial cells 
could have the specific task of presenting Ia plus foreign antigen  to the circulation, 
serving to recruit antigen-specific T  helper cells into the site of an immune response. 
Ia expression would be induced  when needed.  The consequences of inducible Ia on 
vascular endothelium may extend to allograft rejection. Ia-bearing cells are markedly 
more immunogenic  than  Ia-negative cells  (38),  and  this  observation has led  to the 
theory  of Ia-positive passenger  leukocytes  as  being  important  determinants  of the 
rejection  of kidney  and  other  organ  grafts  (39).  Our  data  suggest  that  it  may  be 
important  to  suppress  endothelial  Ia  expression  in  conjunction  with  depletion  of 
passenger leukocytes in order to improve graft survival. POBER  ET  AL.  1351 
Summary 
We  have  used  monoclonal  antibody  binding,  measured  by  radioimmunoassay, 
fluorescence flow cytometry, and uhrastructural  immunocytochemistry, to measure 
expression of Ia antigens on cultured human umbilical vein endothelial (HUVE) cells. 
Under standard culture conditions, HUVE cells do not express Ia antigens. However, 
treatment of  primary HUVE cultures with phytohemagglutinin induces the expression 
of  Ia antigens. Every endothelial cell in the culture becomes Ia-positive and endothelial 
cells appear to synthesize Ia. HLA-A,B is concomitantly increased. The expression of 
Ia appears  to be mediated  by T  cells  because  (a)  pretreatment  of primary HUVE 
cultures  with  OKT3  plus  complement  blocks  the  action  of the  lectins  but  not  of 
medium conditioned by lectin-activated peripheral blood mononuclear cells;  (b)  co- 
culture of endothelial cells with allogeneic T cells, in the absence oflectin, also induces 
endothelial Ia; and (c) human immune (y) interferon, produced by Chinese hamster 
ovary cells transfected with the human )1 interferon gene, directly induces endothelial 
Ia. During co-culture with lymphocytes, about one-third of the endothelial  cells  are 
Ia-positive  after  24  h  and  all  of  the  endothelial  cells  are  Ia-positive  by  72  h. 
Proliferation of allogeneic T  cells starts by 96 h and peaks at  144 h. Thus, endothelial 
Ia appears sufficiently early to be a  determinant for the proliferation of allogeneic T 
cells.  Inducible expression of Ia by endothelium may be important both for allograft 
rejection and for recruitment of circulating T cells into the site of an immune response. 
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